135 related articles for article (PubMed ID: 4060168)
1. Cadmium found in non-soluble fraction of kidney homogenates and its relation to renal dysfunction after cadmium-cysteine administration.
Maitani T; Saito Y; Suzuki KT
Toxicology; 1985 Oct; 37(1-2):27-38. PubMed ID: 4060168
[TBL] [Abstract][Full Text] [Related]
2. Acute renal dysfunction by cadmium injected with cysteine in relation to renal critical concentration of cadmium.
Maitani T; Watahiki A; Suzuki KT
Arch Toxicol; 1986 Feb; 58(3):136-40. PubMed ID: 3964076
[TBL] [Abstract][Full Text] [Related]
3. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
Min KS; Onosaka S; Tanaka K
Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
Dorian C; Gattone VH; Klaassen CD
Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
[TBL] [Abstract][Full Text] [Related]
5. Stress protein synthesis induced by cadmium-cysteine in rat kidney.
Goering PL; Kish CL; Fisher BR
Toxicology; 1993 Dec; 85(1):25-39. PubMed ID: 8291068
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats.
Wang XP; Chan HM; Goyer RA; Cherian MG
Toxicol Appl Pharmacol; 1993 Mar; 119(1):11-6. PubMed ID: 8470114
[TBL] [Abstract][Full Text] [Related]
7. Renal cadmium deposition and injury as a result of accumulation of cadmium-metallothionein (CdMT) by the proximal convoluted tubules--A light microscopic autoradiography study with 109CdMT.
Dorian C; Gattone VH; Klaasen CD
Toxicol Appl Pharmacol; 1992 Jun; 114(2):173-81. PubMed ID: 1609408
[TBL] [Abstract][Full Text] [Related]
8. Influence of chelating agents on toxicity and distribution of cadmium among proteins of mouse liver and kidney following oral or subcutaneous exposure.
Engström B
Acta Pharmacol Toxicol (Copenh); 1981 Feb; 48(2):108-17. PubMed ID: 7257822
[TBL] [Abstract][Full Text] [Related]
9. Cadmium-induced hepatic and renal injury in chronically exposed rats: likely role of hepatic cadmium-metallothionein in nephrotoxicity.
Dudley RE; Gammal LM; Klaassen CD
Toxicol Appl Pharmacol; 1985 Mar; 77(3):414-26. PubMed ID: 3975909
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution of cadmium and nephropathy after administration of cadmium in several chemical forms.
Min KS; Kobayashi K; Onosaka S; Ohta N; Okada Y; Tanaka K
Toxicol Appl Pharmacol; 1986 Nov; 86(2):262-70. PubMed ID: 3787624
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity of intravenously injected cadmium-metallothionein: critical concentration and tolerance.
Maitani T; Cuppage FE; Klaassen CD
Fundam Appl Toxicol; 1988 Jan; 10(1):98-108. PubMed ID: 3350234
[TBL] [Abstract][Full Text] [Related]
12. Distribution of cadmium after oral administration of cadmium-thionein to mice.
Maitani T; Waalkes MP; Klaassen CD
Toxicol Appl Pharmacol; 1984 Jun; 74(2):237-43. PubMed ID: 6740673
[TBL] [Abstract][Full Text] [Related]
13. Non-metallothionein-bound cadmium in the pathogenesis of cadmium nephrotoxicity in the rat.
Goyer RA; Miller CR; Zhu SY; Victery W
Toxicol Appl Pharmacol; 1989 Nov; 101(2):232-44. PubMed ID: 2815080
[TBL] [Abstract][Full Text] [Related]
14. Protective role of renal metallothionein against Cd nephropathy in rats.
Min KS; Hatta A; Onosaka S; Ohta N; Okada Y; Tanaka K
Toxicol Appl Pharmacol; 1987 Apr; 88(2):294-301. PubMed ID: 3564045
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity.
Liu Y; Liu J; Habeebu SM; Waalkes MP; Klaassen CD
Toxicol Sci; 2000 Sep; 57(1):167-76. PubMed ID: 10966523
[TBL] [Abstract][Full Text] [Related]
16. Cadmium, metallothionein and renal tubular toxicity.
Nordberg M; Jin T; Nordberg GF
IARC Sci Publ; 1992; (118):293-7. PubMed ID: 1303954
[TBL] [Abstract][Full Text] [Related]
17. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden.
Vestergaard P; Shaikh ZA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377
[TBL] [Abstract][Full Text] [Related]
18. Long-term turnover of cadmium metallothionein in liver and kidney following a single low dose of cadmium in rats.
Ridlington JW; Winge DR; Fowler BA
Biochim Biophys Acta; 1981 Mar; 673(2):177-83. PubMed ID: 7213819
[TBL] [Abstract][Full Text] [Related]
19. Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice.
Liu J; Liu Y; Habeebu SM; Waalkes MP; Klaassen CD
Toxicology; 2000 Jul; 147(3):157-66. PubMed ID: 10924798
[TBL] [Abstract][Full Text] [Related]
20. Cadmium in rat kidney subcellular particles after injection of cadmium-metallothionein.
Sato M; Nagai Y
J Toxicol Sci; 1986 Feb; 11(1):29-39. PubMed ID: 3712505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
